Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. (2937)
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. (statistical code 2937): imports in August 2026 were JPY 1,472,220,000 (+17.0% year on year), quantity 1,389,242 GR, unit price JPY 1,058 per GR. Main origins: Italy (39.5%), People's Republic of China (29.7%), Israel (23.7%), France (2.4%), United States of America (1.0%). Figures for August 2026 are preliminary.
Exports in the same month were JPY 264,650,000, a trade deficit of JPY 1,207,570,000. (imports: preliminary; exports: revised)
Export statistics for this code
Monthly statistics
| Month | Status | Import value | Quantity | Unit price | Year-on-year |
|---|---|---|---|---|---|
| August 2026 | preliminary | JPY 1,472,220,000 | 1,389,242 | JPY 1,058 | +17.0% |
| July 2026 | revised | JPY 1,910,533,000 | 811,187 | JPY 2,351 | -63.9% |
| June 2026 | revised | JPY 5,191,015,000 | 1,781,398 | JPY 2,912 | +282.5% |
| May 2026 | revised | JPY 972,064,000 | 710,552 | JPY 1,368 | -59.9% |
| April 2026 | revised | JPY 3,315,031,000 | 1,511,403 | JPY 2,193 | -4.1% |
| March 2026 | revised | JPY 3,734,263,000 | 1,236,393 | JPY 3,020 | +69.8% |
| February 2026 | revised | JPY 2,820,940,000 | 965,037 | JPY 2,917 | -36.0% |
| January 2026 | revised | JPY 1,025,466,000 | 840,642 | JPY 1,218 | -17.7% |
| December 2025 | revised (second) | JPY 2,470,210,000 | 1,022,235 | JPY 2,415 | +5.9% |
| November 2025 | revised (second) | JPY 3,352,809,000 | 1,368,978 | JPY 2,448 | -42.3% |
| October 2025 | revised (second) | JPY 3,365,703,000 | 2,431,020 | JPY 1,384 | +4.6% |
| September 2025 | revised (second) | JPY 3,019,570,000 | 1,590,812 | JPY 1,897 | +77.3% |
| August 2025 | revised (second) | JPY 1,258,625,000 | 397,354 | JPY 3,160 | -5.7% |
| July 2025 | revised (second) | JPY 5,297,590,000 | 1,287,630 | JPY 4,114 | +35.1% |
| June 2025 | revised (second) | JPY 1,357,268,000 | 1,368,588 | JPY 990 | -45.0% |
| May 2025 | revised (second) | JPY 2,421,632,000 | 1,335,911 | JPY 1,813 | +14.6% |
| April 2025 | revised (second) | JPY 3,457,943,000 | 1,916,848 | JPY 1,803 | +20.4% |
| March 2025 | revised (second) | JPY 2,199,405,000 | 867,110 | JPY 2,535 | -43.4% |
| February 2025 | revised (second) | JPY 4,410,527,000 | 1,212,371 | JPY 3,636 | +323.2% |
| January 2025 | revised (second) | JPY 1,245,260,000 | 465,359 | JPY 2,492 | -5.5% |
| December 2024 | final | JPY 2,331,614,000 | 682,208 | JPY 3,416 | -31.6% |
| November 2024 | final | JPY 5,808,982,000 | 1,571,694 | JPY 3,694 | +91.9% |
| October 2024 | final | JPY 3,216,511,000 | 1,101,122 | JPY 2,920 | -35.7% |
| September 2024 | final | JPY 1,702,681,000 | 1,157,815 | JPY 1,469 | -53.5% |
Subcategories
- Somatotropin, its derivatives and structural analogues
- Insulin and its salts
- Other
- Cortisone, hydrocortisone, prednisone (dehydrocortisone) and prednisolone (dehydrohydrocortisone)
- Halogenated derivatives of corticosteroidal hormones
- Oestrogens and progestogens
- Other
- Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues
- Other
API and MCP
No API key required. An optional API key gives you a dedicated quota of 1,000 requests per day that is not affected by congestion (free at https://data.washutrading.com/register/).
Example API request for this item: https://data.washutrading.com/api/v1/series?code=2937&flow=import